HighVista Strategies LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1335325 BOSTON, MA

Position in DYN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,316,502

+$2,149,885 QoQ

Shares Held

182,929

+206.7% QoQ

Ownership

0.128%

of shares outstanding

% of Portfolio

0.92%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HighVista Strategies LLC holds $224,607,258 across 76 Biotechnology names. DYN ranks #29 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	113,254	$12,610,832
2	PRAX	Praxis Precision Medicines, Inc.	26,323	$8,481,007
3	COGT	Cogent Biosciences, Inc.	197,051	$7,584,492
4	SYRE	Spyre Therapeutics, Inc.	146,264	$7,377,556
5	PCVX	Vaxcyte, Inc.	124,647	$7,243,237
6	RVMD	Revolution Medicines, Inc.	69,309	$6,740,300
7	TERN	Terns Pharmaceuticals, Inc.	114,307	$6,026,265
8	GPCR	Structure Therapeutics Inc.	123,909	$5,972,413

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,316,502	182,929	+206.7%	Shares	Sole	2026-05-15
2025-12-31	$1,166,617	59,643	+126.6%	Shares	Sole	2026-02-17
2025-06-30	$250,604	26,324	-66.4%	Shares	Sole	2025-08-14
2025-03-31	$820,273	78,420	0.0%	Shares	Sole	2025-05-15
2024-12-31	$1,847,575	78,420	+19.8%	Shares	Sole	2025-02-14
2024-09-30	$2,352,113	65,482	-36.1%	Shares	Sole	2024-11-14
2023-03-31	$1,180,005	102,431	0.0%	Shares	Sole	2023-05-15
2022-12-31	$1,187,175	102,431	0.0%	Shares	Sole	2023-02-14
2022-09-30	$1,300,873	102,431	-57.6%	Shares	Sole	2022-11-14
2022-06-30	$1,661,626	241,867	+43.4%	Shares	Sole	2022-08-15
2022-03-31	$1,626,181	168,691	+610.0%	Shares	Sole	2022-05-16
2020-12-31	$498,960	23,760	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.